Update on the Management of Diabetic Retinopathy: Anti-VEGF Agents for the Prevention of Complications and Progression of Nonproliferative and Proliferative Retinopathy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Update on the Management of Diabetic Retinopathy: Anti-VEGF Agents for the Prevention of Complications and Progression of Nonproliferative and Proliferative Retinopathy
Authors
Keywords
-
Journal
Life-Basel
Volume 13, Issue 5, Pages 1098
Publisher
MDPI AG
Online
2023-04-28
DOI
10.3390/life13051098
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy
- (2023) Raj K. Maturi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The efficacy and safety of intravitreal injection of Ranibizumab as pre-treatment for vitrectomy in proliferative diabetic retinopathy with vitreous hemorrhage
- (2022) Shengguo Li et al. BMC Ophthalmology
- PANRETINAL PHOTOCOAGULATION VERSUS INTRAVITREAL BEVACIZUMAB VERSUS A PROPOSED MODIFIED COMBINATION THERAPY FOR TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY
- (2022) Toktam Shahraki et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Treat-and-Extend Versus Alternate Dosing Strategies with Anti-Vascular Endothelial Growth Factor agents to treat Center Involving Diabetic Macular Edema: A Systematic Review and Meta-analysis of 2346 Eyes
- (2022) Gurkaran S. Sarohia et al. SURVEY OF OPHTHALMOLOGY
- Risk, Prevalence, and Progression of Glaucoma in Eyes with Age-Related Macular Degeneration Treated with Intravitreal Anti-VEGF Injections
- (2022) Saumya M. Shah et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Effect of less aggressive treatment on diabetic retinopathy severity scale scores: analyses of the RIDE and RISE open-label extension
- (2022) Roger A Goldberg et al. BMJ Open Ophthalmology
- Progress and Challenges of Anti-VEGF Agents and Their Sustained-Release Strategies for Retinal Angiogenesis
- (2022) Manhong Xu et al. Drug Design Development and Therapy
- Intravitreal anti-vascular endothelial growth factor versus panretinal LASER photocoagulation for proliferative diabetic retinopathy: a systematic review and meta-analysis
- (2021) William B. Yates et al. CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE
- Topographical Response of Retinal Neovascularization to Aflibercept or Panretinal Photocoagulation in Proliferative Diabetic Retinopathy
- (2021) Sandra Halim et al. JAMA Ophthalmology
- Intravitreal conbercept as an adjuvant in vitrectomy for proliferative diabetic retinopathy: a meta-analysis of randomised controlled trials
- (2021) G. H. Chen et al. EYE
- Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis
- (2021) Zhen Ling Teo et al. OPHTHALMOLOGY
- Effect of Intravitreous Anti–Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy
- (2021) Raj K. Maturi et al. JAMA Ophthalmology
- Visual Acuity, Vitreous Hemorrhage, and Other Ocular Outcomes After Vitrectomy vs Aflibercept for Vitreous Hemorrhage Due to Diabetic Retinopathy
- (2021) Adam R. Glassman et al. JAMA Ophthalmology
- Real-Time Photographic- and Fluorescein Angiographic-Guided Management of Diabetic Retinopathy: Randomized PRIME Trial Outcomes
- (2021) Hannah J. Yu et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy
- (2021) David M. Brown et al. JAMA Ophthalmology
- Evaluation of contrast sensitivity in non-high-risk proliferative diabetic retinopathy treated with panretinal photocoagulation with and without intravitreal injections of ranibizumab
- (2021) Zubir S. Rentiya et al. ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
- Lapses in Care Among Patients Assigned to Ranibizumab for Proliferative Diabetic Retinopathy
- (2021) Maureen G. Maguire et al. JAMA Ophthalmology
- NEW BIOMARKER QUANTIFYING THE EFFECT OF ANTI-VEGF THERAPY IN EYES WITH PROLIFERATIVE DIABETIC RETINOPATHY ON ULTRAWIDE FIELD FLUORESCEIN ANGIOGRAPHY
- (2021) Wenying Fan et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- RETINAL LEAKAGE INDEX DYNAMICS ON ULTRA-WIDEFIELD FLUORESCEIN ANGIOGRAPHY IN EYES TREATED WITH INTRAVITREAL AFLIBERCEPT FOR PROLIFERATIVE DIABETIC RETINOPATHY IN THE RECOVERY STUDY
- (2020) Amy S. Babiuch et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Visual Field Changes Over 5 Years in Patients Treated With Panretinal Photocoagulation or Ranibizumab for Proliferative Diabetic Retinopathy
- (2020) Maureen G. Maguire et al. JAMA Ophthalmology
- Effect of intravitreal ranibizumab pretreatment on vitrectomy in young patients with proliferative diabetic retinopathy
- (2020) Hui-Jin Chen et al. Annals of Palliative Medicine
- Intravitreal Aflibercept injection with Panretinal photocoagulation versus early Vitrectomy for diabetic vitreous hemorrhage: randomized clinical trial
- (2020) Ahmed Hosni Abd Elhamid et al. BMC Ophthalmology
- Predictors of Lost to Follow-Up in Patients Being Treated for Proliferative Diabetic Retinopathy
- (2020) Michael Green et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Longitudinal panretinal microaneurysm dynamics on ultra-widefield fluorescein angiography in eyes treated with intravitreal aflibercept for proliferative diabetic retinopathy in the recovery study
- (2020) Amy Babiuch et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
- (2020) Andrew N. Antoszyk et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of Intravitreal Anti–Vascular Endothelial Growth Factor Therapy With Risk of Stroke, Myocardial Infarction, and Death in Patients With Exudative Age-Related Macular Degeneration
- (2019) Lauren A. Dalvin et al. JAMA Ophthalmology
- PHOTOCOAGULATION VERSUS RANIBIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY
- (2019) Susan B. Bressler et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Change in cardiac troponin T level after intravitreal anti-vascular endothelial growth factor treatment: Prospective pilot study
- (2019) Abdallah G Rebeiz et al. EUROPEAN JOURNAL OF OPHTHALMOLOGY
- Preoperative Intravitreal Bevacizumab for Tractional Retinal Detachment Secondary to Proliferative Diabetic Retinopathy: Prospective Randomized Clinical Trial of the Pan-American Collaborative Retina Study (PACORES) Group*
- (2019) J.Fernando Arevalo et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Panretinal Photocoagulation for Diabetic Retinopathy in the RIDE and RISE Trials: Not “One and Done”
- (2019) Victor H. Gonzalez et al. OPHTHALMOLOGY
- ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND RISK OF TRACTION RETINAL DETACHMENT IN EYES WITH PROLIFERATIVE DIABETIC RETINOPATHY
- (2019) Neil M. Bressler et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Intravitreal ranibizumab for persistent diabetic vitreous haemorrhage: a randomised, double‐masked, placebo‐controlled feasibility study.
- (2019) Robert Petrarca et al. ACTA OPHTHALMOLOGICA
- Five-Year Cost-effectiveness of Intravitreous Ranibizumab Therapy vs Panretinal Photocoagulation for Treating Proliferative Diabetic Retinopathy
- (2019) David W. Hutton et al. JAMA Ophthalmology
- The Risk of Primary Open-Angle Glaucoma Following Vitreoretinal Surgery—A Population-based Study
- (2018) Sasha A. Mansukhani et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Clinical pharmacology of intravitreal anti-VEGF drugs
- (2018) Stefano Fogli et al. EYE
- Overview of Systematic Reviews and Meta-analyses on Systemic Adverse Events Associated With Intravitreal Anti–Vascular Endothelial Growth Factor Medication Use
- (2018) Marie Thulliez et al. JAMA Ophthalmology
- Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti–Vascular Endothelial Growth Factor
- (2018) Anthony Obeid et al. OPHTHALMOLOGY
- Rationale and Application of the Protocol S Anti–Vascular Endothelial Growth Factor Algorithm for Proliferative Diabetic Retinopathy
- (2018) Jennifer K. Sun et al. OPHTHALMOLOGY
- Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy
- (2018) Jeffrey G. Gross et al. JAMA Ophthalmology
- Panretinal Photocoagulation Plus Intravitreal Bevacizumab Versus Panretinal Photocoagulation Alone for Proliferative Diabetic Retinopathy
- (2018) JCPSP-Journal of the College of Physicians and Surgeons Pakistan
- Durability of Diabetic Retinopathy Improvement with As-Needed Ranibizumab: Open-label Extension of RIDE and RISE Studies
- (2018) Jennifer K. Sun et al. OPHTHALMOLOGY
- OUTCOMES OF AN INTRAVITREAL INJECTION CLINIC
- (2017) Elizabeth A. Atchison et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Panretinal Photocoagulation: A Review of Complications
- (2017) Shivani V. Reddy et al. Seminars in Ophthalmology
- Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature
- (2013) K Ghasemi Falavarjani et al. EYE
- Adverse Events After Pars Plana Vitrectomy Among Medicare Beneficiaries
- (2009) Joshua D. Stein ARCHIVES OF OPHTHALMOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started